The Abell Foundation made a net investment of $500,000 in Harpoon Medical in 2014-15. When Edwards Lifesciences (NYSE: EW) closed its $100 million acquisition of Harpoon two weeks ago, Abell earned $5.2 million, a 10-times return on Abell’s investment with the possibility of additional milestone payments.
Here is my lunch with David Wise who was the Venture Advisor for the Abell Foundation when the investment in Harpoon Medical was made.